TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Tataa Biocenter AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
36,711
|
52,159
|
36,724 |
| Financial expenses |
1
|
7
|
359 |
| Earnings before taxes |
-49,899
|
-60,357
|
-60,507 |
| EBITDA |
-44,966
|
-54,522
|
-54,490 |
| Total assets |
36,182
|
43,799
|
44,339 |
| Current assets |
24,017
|
26,782
|
22,667 |
| Current liabilities |
16,632
|
14,295
|
26,601 |
| Equity capital |
19,550
|
29,504
|
17,738 |
| - share capital |
139
|
139
|
139 |
| Employees (average) |
41
|
46
|
47 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
54.0%
|
67.4%
|
40.0% |
| Turnover per employee |
895
|
1,134
|
781 |
| Profit as a percentage of turnover |
-135.9%
|
-115.7%
|
-164.8% |
| Return on assets (ROA) |
-137.9%
|
-137.8%
|
-135.7% |
| Current ratio |
144.4%
|
187.4%
|
85.2% |
| Return on equity (ROE) |
-255.2%
|
-204.6%
|
-341.1% |
| Change turnover |
-15,448
|
15,435
|
-57,487 |
| Change turnover % |
-30%
|
42%
|
-61% |
| Chg. No. of employees |
-5
|
-1
|
6 |
| Chg. No. of employees % |
-11%
|
-2%
|
15% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.